LAB B logo

Genomma Lab Internacional, S.A.B. de C.V. Stock Price

BMV:LAB B Community·Mex$17.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 16 Fair Values set on narratives written by author

LAB B Share Price Performance

Mex$17.96
-6.40 (-26.27%)
Mex$20.00
Fair Value
Mex$17.96
-6.40 (-26.27%)
10.2% undervalued intrinsic discount
Mex$20.00
Fair Value
Price Mex$17.96
AnalystLowTarget Mex$20.00
AnalystConsensusTarget Mex$26.80
AnalystHighTarget Mex$30.00

LAB B Community Narratives

AnalystLowTarget·
Fair Value Mex$20 10.2% undervalued intrinsic discount

Seasonal Volatility And Cost Cuts Will Test Margin Ambitions Yet Support A Cautious Upside View

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value Mex$26.8 33.0% undervalued intrinsic discount

Productivity Program And E Commerce Expansion Will Drive Long Term Market Share Gains

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystHighTarget·
Fair Value Mex$30 40.1% undervalued intrinsic discount

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
LAB B logo
Genomma Lab Internacional. de

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more

View narrative
0
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Mex$30
40.1% undervalued intrinsic discount
Revenue
8.7% p.a.
Profit Margin
14.62%
Future PE
12.93x
Price in 2029
Mex$44.65
LAB B logo
Genomma Lab Internacional. de

Seasonal Volatility And Cost Cuts Will Test Margin Ambitions Yet Support A Cautious Upside View

Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more

View narrative
2
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Mex$20
10.2% undervalued intrinsic discount
Revenue
4% p.a.
Profit Margin
12.54%
Future PE
11.37x
Price in 2029
Mex$29.77
LAB B logo
Genomma Lab Internacional. de

Productivity Program And E Commerce Expansion Will Drive Long Term Market Share Gains

Catalysts About Genomma Lab Internacional. de Genomma Lab Internacional.Read more

View narrative
8
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Mex$26.8
33.0% undervalued intrinsic discount
Revenue
6.13% p.a.
Profit Margin
13.83%
Future PE
12.95x
Price in 2028
Mex$39.99

Trending Discussion

Updated Narratives

LAB B logo

Productivity Savings And Channel Expansion Will Support A Stronger Long Term Earnings Profile

Fair Value: Mex$30 40.1% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LAB B logo

Seasonal Volatility And Cost Cuts Will Test Margin Ambitions Yet Support A Cautious Upside View

Fair Value: Mex$20 10.2% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LAB B logo

Productivity Program And E Commerce Expansion Will Drive Long Term Market Share Gains

Fair Value: Mex$26.8 33.0% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet and undervalued.

0 Risks
3 Rewards

Genomma Lab Internacional, S.A.B. de C.V. Key Details

Mex$17.5b

Revenue

Mex$6.5b

Cost of Revenue

Mex$11.0b

Gross Profit

Mex$9.4b

Other Expenses

Mex$1.6b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
1.65
62.84%
9.16%
0%
View Full Analysis

About LAB B

Founded
1996
Employees
1708
CEO
Juan Marco Sparvieri
WebsiteView website
www.genommalab.com

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Genomma Lab Internacional, S.A.B. de C.V. Competitors